BIOMAT Database Logo BIOMAT Database Logo

To perfuse or not to perfuse? A retrospective comparative study to evaluate the effect of adjuvant isolated regional perfusion in patients with stage I extremity melanoma with a thickness of 1.5 mm or greater. 1988

H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
Division of Clinical Oncology, The Netherlands Cancer Institute, Amsterdam.

The use of isolated regional perfusion in an adjuvant setting for stage I melanoma of the extremity continues to be controversial. The present retrospective study evaluates the past 20 years' experience by comparing 227 perfused patients from Groningen with 238 matched controls from five hospitals in The Netherlands and Westphalia (a region of West Germany bordering the Netherlands). All patients underwent wide local excision for a primary extremity melanoma of 1.5 mm or greater in thickness. A proportional hazards regression analysis for recurrence of disease and survival identified the significant prognostic factors, of which tumor thickness was the most important. Corrected for these factors, it was not possible to demonstrate a statistically significant effect for perfusion in terms of time to limb recurrence (P = .61), time to regional lymph node metastasis (P = .11), time to distant metastasis (P = .73), disease-free interval (P = .42), and survival (P = .90). No statistically significant differences were seen for adjuvant perfusion in any of the subgroups.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females

Related Publications

H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
[Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
October 1990, Nederlands tijdschrift voor geneeskunde,
H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion.
November 1981, Cancer,
H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.
January 1992, World journal of surgery,
H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
Hyperthermic adjuvant perfusion chemotherapy for Stage I malignant melanoma of the extremity with literature review.
December 1983, Cancer,
H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
A prospective randomized study of regional extremity perfusion in patients with malignant melanoma.
December 1984, Annals of surgery,
H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.
April 1993, Journal of surgical oncology,
H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
Comparison of two methods of treating primary malignant melanomas Clark IV and V, thickness 1.5 mm and greater, localized on the extremities. Wide surgical excision with and without adjuvant regional perfusion.
May 1986, Cancer,
H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
A retrospective study of regional perfusion for melanoma.
April 1976, Archives of surgery (Chicago, Ill. : 1960),
H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
Isolated limb perfusion for stage I melanoma of the extremity: a comparison of melphalan and dacarbazine (DTIC).
August 1989, Southern medical journal,
H R Franklin, and H Schraffordt Koops, and J Oldhoff, and B M Czarnetzki, and E Macher, and B B Kroon, and K Welvaart, and J W van der Velden, and E van Dijk, and E P van der Esch
Indications for elective groin dissection in clinical stage I patients with malignant melanoma of the lower extremity treated by hyperthermic regional perfusion.
October 1983, Cancer,
Copied contents to your clipboard!